TNGX
NASDAQTango Therapeutics
$31.56
+0.63 (+2.04%)
Institutional
127.4%
Insider
1.38%
Retail/Other
-28.8%
Shares Outstanding
144.6M
Top Institutional Holders
As of Jun 2026| Holder | Shares | % | Change |
|---|---|---|---|
| RTW INVESTMENTS, LLC | 13.3M | 9.2% | +11.8M |
| Adage Capital Partners Gp LLC | 12.8M | 8.9% | +2.2M |
| Boxer Capital Management, LLC | 10.9M | 7.5% | - |
| EcoR1 Capital, LLC | 10.6M | 9.6% | - |
| TCG Crossover Management, LLC | 10.5M | 7.3% | -2.2M |
| FMR Inc | 9.9M | 6.9% | +7.0M |
| Farallon Capital Management, L.L.C. | 9.1M | 6.3% | -4.0M |
| BlackRock Inc | 8.7M | 6.1% | +0.2M |
| Woodline Partners LP | 8.0M | 5.5% | -2.1M |
| Nextech Invest, Ltd. | 7.3M | 5.0% | +1.7M |
Insider Transactions
Last 24 months (9 insiders)
Barbara Weber
Director, Executive Chair
1,629,587 shares
Sales (2)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 30,186 | $12.26 | $369,999 | 2026-02-03 | 1,629,587 |
| 333 | $12.90 | $4,295 | 2026-02-03 | 1,629,254 |
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 37,522 | - | $448,013* | 2026-02-02 | 1,659,773 |
Malte Peters
President & CEO
367,500 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 350,000 | - | $3,869,250* | 2026-01-08 | 367,500 |
Daniella Beckman
Chief Financial Officer
184,297 shares
Sales (2)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 113 | $12.90 | $1,457 | 2026-02-03 | 184,297 |
| 10,204 | $12.26 | $125,073 | 2026-02-03 | 184,410 |
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 44,330 | - | $529,300* | 2026-02-02 | 194,614 |
Adam Crystal
President, R&D
136,603 shares
Sales (9)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 6,140 | $22.25 | $136,627 | 2026-06-01 | 136,603 |
| 20,860 | $23.06 | $480,944 | 2026-06-01 | 115,743 |
| 1,100 | $22.00 | $24,196 | 2026-05-01 | 115,743 |
| 25,900 | $21.19 | $548,901 | 2026-05-01 | 116,843 |
| 38,460 | $25.00 | $961,500 | 2026-04-15 | 112,622 |
| 27,000 | $21.20 | $572,478 | 2026-04-01 | 112,622 |
| 20,251 | $15.00 | $303,765 | 2026-03-05 | 112,622 |
| 201 | $12.90 | $2,592 | 2026-02-03 | 187,218 |
| 18,251 | $12.26 | $223,708 | 2026-02-03 | 187,419 |
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 47,460 | - | $566,672* | 2026-02-02 | 205,670 |
Mace Rothenberg
Director
41,500 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 4,000 | - | $80,880* | 2026-06-05 | 41,500 |
Matthew Gall
Chief Financial Officer
40,000 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 40,000 | - | $839,200* | 2026-05-01 | 40,000 |
John B Ketchum
Director
24,937 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 4,000 | - | $80,880* | 2026-06-05 | 24,937 |
Sung Lee
Director
22,870 shares
Awards (2)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 570 | - | $11,525* | 2026-06-05 | 22,870 |
| 10,000 | - | $89,300* | 2026-01-02 | 10,000 |
Lesley Ann Calhoun
Director
16,500 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 4,000 | - | $80,880* | 2026-06-05 | 16,500 |
Insider Activity Summary
Last 24 monthsTotal Bought
0 shares
$0
Total Sold
198,999 shares
$3,755,537
Net Shares
-198,999
Net Value
$-3,755,537
Activity by Insider
| Name | Bought | Sold | Net Shares | Net Value |
|---|---|---|---|---|
|
Adam Crystal
President, R&D
|
- | -158,163 | -158,163 | $-3,254,712 |
|
Barbara Weber
Director, Executive Chair
|
- | -30,519 | -30,519 | $-374,294 |
|
Daniella Beckman
Chief Financial Officer
|
- | -10,317 | -10,317 | $-126,531 |
Net insider selling: 198,999 shares ($3,755,537) in last 12 months
Congressional Trading
STOCK Act DisclosuresNo congressional trading data available for this ticker.
Congressional trading data is sourced from STOCK Act disclosures and may not be available for all tickers.
Based on public disclosures. Reporting errors by representatives are common. Disclosure deadlines are 45 days after transaction.